Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)

Small Molecules Studied

  • Page 1 of 4
  • 1 to 25 of 95 Small Molecules
HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10236-1 17-AAG
Tanespimycin
LSM-43239 151069
10237-1 5-DFUR
5-FdUR; Doxifluridine
LSM-6359 18343
10238-1 5-FU
Fluorouracil
LSM-4261 3385
10133-2 Afatinib
BIBW-2992
LSM-43226 57519523
10239-1 AG1024
Tyrphostin AG 1024
LSM-4262 2044
10223-2 AG1478
Tyrphostin
LSM-1224 2051
10240-1 AS-252424 LSM-4263 56965900
10343-1 Baicalein LSM-6355 5281605
10241-4 Bortezomib
Velcade
LSM-6281 387447
10241-1 Bortezomib
Velcade
LSM-6281 387447
10241 Bortezomib
Velcade
LSM-6281 387447
10189-2 Bosutinib
SKI-606
LSM-1190 5328940
10242-1 Carboplatin LSM-44959 5237030
10243-1 CGC-11047
PG11047
LSM-4266 476863
10245-1 Cisplatin
CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat
LSM-4268
10246-1 CPT-11
Irinotecan
LSM-2167 60838
10232-2 Dactolisib
BEZ235; NVP-BEZ235
LSM-4255 11977753
10506-1 Dichloroacetate 25975
10507-1 Disulfiram
Tetraethylthiuram disulfide; TETD
3117
10247-1 Docetaxel
Taxotere
LSM-6360 148124
10248-1 Doxorubicin
Adriamycin
LSM-4062 31703
10249-1 Epirubicin
Ellence
LSM-2078 41867
10097-3 Erlotinib
OSI-774
LSM-1097 176870
10250-1 Etoposide LSM-6348 36462
10235-2 Everolimus
RAD001
LSM-4258 53398658
  • Page 1 of 4
  • 1 to 25 of 95 Small Molecules